1. Home
  2. UIS vs NTHI Comparison

UIS vs NTHI Comparison

Compare UIS & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unisys Corporation New

UIS

Unisys Corporation New

N/A

Current Price

$2.37

Market Cap

205.4M

Sector

Technology

ML Signal

N/A

NTHI

NeOnc Technologies Holdings Inc.

N/A

Current Price

$9.49

Market Cap

243.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UIS
NTHI
Founded
1942
2008
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.4M
243.9M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
UIS
NTHI
Price
$2.37
$9.49
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$5.67
N/A
AVG Volume (30 Days)
952.4K
31.7K
Earning Date
05-26-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,950,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.11
$3.20
52 Week High
$5.33
$16.00

Technical Indicators

Market Signals
Indicator
UIS
NTHI
Relative Strength Index (RSI) 47.24 48.15
Support Level $2.11 $8.43
Resistance Level $2.65 $10.52
Average True Range (ATR) 0.12 0.67
MACD 0.03 -0.06
Stochastic Oscillator 46.67 37.18

Price Performance

Historical Comparison
UIS
NTHI

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Share on Social Networks: